Alzheimer drugs halted
Savings to go to Alzheimer care services
27 June 2018
By Connexion journalistFour Alzheimer drugs costing the health service €90million a year will no longer be reimbursed as the ministry moves to stop them being prescribed due to harmful side effects, which include falls and broken bones.
Savings on Aricept, Ebixa, Exelon, Reminyl and generics will go to Alzheimer care services.
More from French news
More from Connexion
Stay informed, have your say, join the community
Boost your inbox with our editor’s pick of news and information about France for residents and second homeowners
By joining the newsletter, you agree to our Terms & Conditions and Privacy Policy
1
Covid France: 10 departments worsen, PM to update tomorrow
3 days ago2
Covid France: 20 departments monitored for stricter measures
1 day ago3
Coronavirus: Daily updates on the situation in France
9 hours ago4
New Covid variant more resistant to vaccines found in France
5 days ago5
Covid vaccine France: When will I get my first jab?
3 days agoSee more popular articles
The Connexion Help Guides
Brexit and Beyond for Britons in France
Inheritance Law and Wills in France More from French news
More from Connexion
Get news, views and information from France
